Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament Analyses.

Muscle & nerve·2026

Same author

Tofersen, SOD1, and the Treatability of Amyotrophic Lateral Sclerosis.

JAMA neurology·2025

Same author

Epigenetic profiles of tissue informative CpGs inform ALS disease status and progression.

Genome medicine·2025

Same author

Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment.

Annals of neurology·2025

Same author

Characteristics and Motivations of People With Amyotrophic Lateral Sclerosis Who Pursue Medical Aid in Dying in California.

Neurology. Clinical practice·2025

Same author

Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for clinicians.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2024

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Amyotrophic lateral sclerosis from bench to bedside.

Catherine Lomen-Hoerth¹

¹Department of Neurology, University of California, San Francisco, 350 Parnassus Avenue, Suite 500, San Francisco, CA 94117, USA. catherine.lomen-hoerth@ucsf.edu

Seminars in Neurology

|March 21, 2008

Summary

Amyotrophic lateral sclerosis (ALS) is a rare, progressive neurodegenerative disease with no cure. Research is exploring genetic causes and potential links with dementia for new treatment strategies.

More Related Videos

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)

Published on: March 17, 2012

Related Experiment Videos

Last Updated: Jul 6, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)

Published on: March 17, 2012

Area of Science:

Neurology
Genetics
Neurodegenerative Diseases

Background:

Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neurodegenerative disorder.
Current treatments do not alter the disease's fatal progression.
The exact cause of ALS remains largely unknown, though genetic factors are identified in familial cases.

Purpose of the Study:

To summarize the current understanding of Amyotrophic lateral sclerosis (ALS).
To highlight challenges in ALS diagnosis and the potential of understanding its overlap with dementia.
To review advancements in symptomatic treatments and quality of life improvements for ALS patients.

Main Methods:

Review of existing literature on Amyotrophic lateral sclerosis (ALS).
Analysis of genetic findings in familial ALS cases.
Examination of diagnostic challenges and differential diagnoses for ALS.

Main Results:

ALS affects approximately 1 in 100,000 individuals globally.
Genetic research has identified causative factors in familial ALS.
Technological advancements have improved quality of life and symptomatic management for ALS patients.

Conclusions:

There is a critical need for effective treatments to alter the fatal course of ALS.
Investigating the overlap between ALS and dementia may offer insights into disease mechanisms and therapeutic targets.
Continued research into genetic causes and symptomatic relief is vital for managing ALS.